Wepreviously reported that the introduction of a methylene spacer at the C-5' position of carbapenem antibiotics bearing 5'-aminocarbonylpyrrolidin-3'-ylthio group as a C-2 side chain enhances the stability to renal dehydropeptidase-I (DHP-I)1*. In this study, the effect on DHP-I stability by introduction of methyl group on the nitrogen atom of the pyrrolidine ring was investigated. It was found that the Af-methylation effectively increased the stability beyond our expectations. The present paper describes the antibacterial activity and the stability to DHP-I of l/?-methylcarbapenems with TV-methylated pyrrolidinylthio side chain (1 and 2). 
Chemistry
The title compoundswere synthesized as shown in Schemes 1 and 2. The mercaptans (7a~7f) used in this work were prepared as follows. TV-Protected pyrrolidine (3) was derived from mms-4-hydroxy-Lproline according to the reported procedure1>2). Removal of the benzyloxycarbonyl group of 3 was carried out by hydrogenolysis over 10%Pd-C to give 4-hydroxypyrrolidine (4) . Reductive 7V-methylation of 4 was accomplished by treatment with formaldehyde over 10%Pd-C in a hydrogen atmosphere to give TV-methylpyrrolidine (5) . The hydroxyl group of 5 was transformed by a modified Mitsunobu reaction3}, using triphenyl phosphine, diethyl azodicarboxylate and thioacetic acid, into the acetylthio group with inversion ofC-4 configuration. Thioacetate (6) was treated with sodium methoxide to provide mercaptan (7) .
Protected l/?-methylcarbapenem (9) was obtained by treatment of enol phosphate (8)4) with the freshly prepared mercaptan (7) in the presence ofdiisopropylethylamine.
The/?-nitrobenzyl group of9 was removed by hydrogenolysis over 10%Pd-C in the presence of 3-(A^-morpholino)propanesulfonic acid (MOPS)buffer (pH 7.0) to afford the target l/?-methylcarbapenem (1), after purification by column chromatography on Diaion CHP-20P. With the aim of studying further of N-methylation, the N,TV-dimethylpyrrolidine derivative (2)5) was prepared by treatment of 9a with methyl iodide followed by removal of the protecting group. VOL.45 NO.6 THE JOURNAL OF ANTIBIOTICS 973 Biological Properties and Discussion The stability to DHP-I and the MICs of the new series of l/?-methylcarbapenems are listed in Table   1 with those of the reference compounds 102) and 111).
The l/?-methylcarbapenems substituted with methyl group on the nitrogen atom of the pyrrolidine ring exhibited potent antibacterial activities against Gram-positive and Gram-negative bacteria. However, comparing with the TV-unsubstituted compounds, these compoundsshowed slightly lower activities against Gram-negativebacteria and their activities against Pseudomonas aeruginosa were significantly decreased.
Comparison of la and 2 demonstrated that further TV-methylation did not affected anti-pseudomonal activity but resulted in reduced activities against other bacteria. It is interestingly to note that dimethylaminocarbonyl derivatives (la and 2) are more active compounds against P. aeruginosa compared with other 5'-aminocarbonyl derivatives (1b, lc and Id).
As for the stability to DHP-I, TV-methyl substitution resulted in.a 5 -7-fold increased stability when compared with the TV-unsubstituted derivatives. The stabilizing effect was comparable to that of the introduction of a methylene spacer (CH2)n at the C-5' position of the pyrrolidine ring. TV,TVdimethylpyrrolidine derivative (2) was 2-fold more stable than la. The 1^-methylcarbapenems (le and If) having both TV-methyl group and methylene spacer exhibited excellent stability to DHP-I. This suggests that the introduction of a methylene spacer in the series of TV-methylated compounds enhances the DHP-I stability synergetically.
It is possible that the highly improved stability is related to basicity and steric crowding of the amino group of pyrrolidinylthio side chain. That is, the introduction of methylene spacer at the C-5' position increases the basicity of the nitrogen atom of the pyrrolidine ring and the TV-substitution with a methyl group enhances the steric crowding of the amino group. Hence, the basicity and steric factor on the nitrogen atom of the pyrrolidinylthio side chain are likely to be important for the stabilization toward DHP-I as well as the orientation of methyl group at the C-l position2'6). a jS-Lactamase producing strain.
b DHP-I stability7* is given relative to compound 10.
Abbreviations: S.a., Staphylococcus aureus; S.p., Streptococcuspyogenes; Ex., Escherichia coli; K.p., Klebsiella pneumoniae; P.m., Proteus mirabilis; P.a., Pseudomonas aeruginosa; S.m., Serratia marcescens; P.v., Proteus vulgaris; N.D., not determined. (25,4jR )-2-Dimethylaminocarbonyl-4-hydroxy-1 -methylpyrrolidine (5a) To a solution of4a (0.89g, 5.63mmol) and 37% aqueous formaldehyde (0.55 g, 6.78mmol) in AcOH (4.5ml) and water (4.0ml) was added 10% Pd-C (0.45g). The mixture was stirred under hydrogen atmosphere for 3 hours at room temperature. The catalyst was filtered off and washed with EtOH, and the combinedfiltrate and washings were evaporated in vacuo. The oily residue was dissolved in CH2C12 (50ml) and then stirred with MgSO4(2.0g) and K2CO3(2.0g) for 1 hour at room temperature. The insoluble salts were removed by filtration and the filtrate was concentrated in vacuo to give crude 5a as a pale yellow oil (775mg, 80%): (2S,4S)-4-Acetylthio-2-dimethylaminocarbonyl-1 -methylpyrrolidine (6a) To a solution of 5a (430mg, 2.5mmol) and triphenylphosphine (1.18 g, 4.5mmol) in THF (5ml) was added dropwise diethyl azodicarboxylate (0.7ml, 4.5 mmol) at 0-5°C under nitrogen atmosphere and stirred for 30minutes at the same temperature. Thioacetic acid (685 mg, 9.0mmol) was added dropwise to the mixture and followed by stirring for 30minutes at 0-5°C and then overnight at room temperature. Thereaction mixture wasconcentrated in vacuo to give an oily residue which waspurified by column chromatography on silica gel using toluene -EtOAc, EtOAc and EtOAc-Me2CO.The fractions eluted with EtOAc-Me2CO(3 : 1 and 1 : 1) were concentrated in vacuo to give 6a as a colorless oil (291 mg, 50%):
[a]£6 -56.3°(c 0.50, MeOH); IR (neat) cm"1 1685, 1640; XH NMR (CDC13) The following compounds (6b-6f) were prepared in a similar manner to that described above. To a solution of6a (0.66g, 2.87mmol) in MeOH(6.6ml) was added 28% MeOHsolution of sodium methoxide (575 mg, 1.04 mmol) at 0~.5°C and stirred for 15 minutes at the same temperature. After addition of 6n HC1(1.05ml), the reaction mixture was concentrated in vacuo to give an oily residue which was dissolved in CHCl3 -MeOH(4: 1). The solution was dried over Na2SO4and evaporated in vacuo to give 7a as a hydrochloric acid salt, which was used in the next step without purification: IR (neat) cm~1 1655. The following compounds (9b~9f) were prepared in a similar manner to that described above. ethyl]-! -methylcarbapen-2-em-3-carboxylic Acid (la) A mixture of9a (64mg, 0.12mmol) and 10% Pd-C (52mg) in THF (3.5ml) and 0.6m MOPSbuffer (3.5 ml) was stirred under hydrogen atmosphere for 5 hours at room temperature. The catalyst was filtered off and THFwas evaporated in vacuo from the filtrate. The residual solution was washed with CH2C12. The separated aqueous layer was concentrated briefly to remove any residual organic solvents in vacuo and then subjected to column chromatography on Diaion CHP-20P.The fractions eluted with water containing 1% ofTHF were combined and lyophilized to give la (30mg, 63%) as a colorless powder: IR
